Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...